Alzheimer's disease and its Lewy body variant: A clinical analysis of postmortem verified cases

American Journal of Psychiatry

Volumn 153, Issue 10, 1996, Pages 1269-1273

  Weiner, Myron F ^a,b   Risser, Richard C ^a   Cullum, C Munro ^a   Honig, Lawrence ^a   White III, Charles ^a   Speciale, Samuel ^a   Rosenberg, Roger N ^a  

^a Univ of Texas S W Medical Center   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; NEUROLEPTIC AGENT; NEUROTRANSMITTER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BODY HEIGHT; BODY SIZE; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DELUSION; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HALLUCINATION; HAMILTON SCALE; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL;

EID: 10144251745     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.10.1269     Document Type: Article

References (22)

1. Hansen LA: Pathology of the other dementias, in Alzheimer Disease. Edited by Terry RD, Katzman R, Bick KL. New York, Raven Press, 1994, pp 167-177
2. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter K, Klauber M, Rice V, Butters N, Alford M: The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990; 40:1-8
3. Galasko D, Hansen L, Katzman R, Wiederholt W, Masliah E, Terry R, Hill R, Lessin P, Thai L: Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994; 51:888-895
4. de Vos RAI, Jansen EN, Stam FC, Rivka R, Swaab DF: "Lewy body disease": clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 1995; 97:13-22
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dosage of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923
6. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid beta-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:9649-9653
7. Galasko D, Saitoh T, Xia Y, Thai LJ, Katzman R, Hill LR, Hansen L: The apolipoprotein E allele e4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44:1950-1951
8. Lippa CF, Smith TW, Saunders AM, Crook R, Pulaski-Salo D, Davies P, Hardy J, Roses AD, Dickson D: Apolipoprotein E genotype and Lewy body disease. Neurology 1995; 45:97-103
9. McKeith IG, Perry RH, Fairbairn AF, Jabeen N, Perry ER: Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22:911-922
10. Mirra SS, Heyman A, McKeel D, Sumi SM, Cram BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486
11. Hachinski VC, Iliff L, Zilkha E, Du Boulay GH, McAllister VL, Marshall J, Russell RWR, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975; 32:632-637
12. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
13. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968; 114:797-811
14. Hughes C, Berg L, Danziger W: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
15. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
16. Kaplan E, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983
17. Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolson LT: Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990; 40:1523-1528
18. McKeith IG, Fairbairn AF, Perry RH, Thompson P: The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 1994; 165:324-332
19. Förstl H, Burns A, Luthert P, Cairns N, Levy R: The Lewy-body variant of Alzheimer's disease. Br J Psychiatry 1993; 162:385-392
20. Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L: Significance of decreased lumbar CSF levels of HVA and 5HIAA in Alzheimer's disease. Neurobiol Aging 1991; 13:107-113
21. Stawarz RJ, Hill H, Robinson SE, Setler P, Dingell JV, Sulser F: On the significance of the increase of homovanillic acid caused by antipsychotic drugs in corpus striatum and limbic forebrain. Psychopharmacologia 1975; 43:125-130
22. Post RM, Goodwin FK: Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients. Science 1975; 190: 488-489